Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Berger

Showing results (1031-1040 of 1,161) with videos related to

Pageof 117
Sort By:
Biorxiv : the Preprint Server for Biology|September 4, 2024
Tracking clonal evolution of drug resistance in ovarian cancer patients by exploiting structural variants in cfDNAMarc J Williams, Ignacio Vázquez-García, Grittney Tam, et al.
Leukemia|May 15, 2007
A comprehensive genetic and histopathologic analysis identifies two subgroups of B-cell malignancies carrying a t(14;19)(q32;q13) or variant BCL3-translocationJ I Martín-Subero, R Ibbotson, W Klapper, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 11, 2018
Ado-Trastuzumab Emtansine for Patients With HER2-Mutant Lung Cancers: Results From a Phase II Basket TrialBob T Li, Ronglai Shen, Darren Buonocore, et al.
Trials|February 24, 2022
CeRebrUm and CardIac Protection with ALlopurinol in Neonates with Critical Congenital Heart Disease Requiring Cardiac Surgery with Cardiopulmonary Bypass (CRUCIAL): study protocol of a phase III, randomized, quadruple-blinded, placebo-controlled, Dutch multicenter trialRaymond Stegeman, Maaike Nijman, Johannes M P J Breur, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 3, 2022
Phase Ib Trial of the Combination of Imatinib and Binimetinib in Patients with Advanced Gastrointestinal Stromal TumorsPing Chi, Li-Xuan Qin, Niedzica Camacho, et al.
Cancer|August 5, 2021
Pancreas cancer and BRCA: A critical subset of patients with improving therapeutic outcomesParisa Momtaz, Catherine A O'Connor, Joanne F Chou, et al.
Cancer Cell|October 27, 2023
Tumor sequencing of African ancestry reveals differences in clinically relevant alterations across common cancersEvelyn Jiagge, Dexter X Jin, Justin Y Newberg, et al.
Gynecologic Oncology|May 7, 2023
Germline drivers of gynecologic carcinosarcomasTiffany Y Sia, Sushmita B Gordhandas, Ozge Birsoy, et al.
Cell|December 19, 2024
Pan-cancer analysis of biallelic inactivation in tumor suppressor genes identifies KEAP1 zygosity as a predictive biomarker in lung cancerMark Zucker, Maria A Perry, Samuel I Gould, et al.
JCO Precision Oncology|September 16, 2025
Clinical Utility and Prognostic Implications of Circulating Cell-Free DNA in Biliary Tract CancerDarren Cowzer, Madison Darmofal, Kenneth Seier, et al.
Pageof 117

Showing results (1031-1040 of 1,161) with videos related to

Sort By:
Pageof 117
Biorxiv : the Preprint Server for Biology|September 4, 2024
Tracking clonal evolution of drug resistance in ovarian cancer patients by exploiting structural variants in cfDNAMarc J Williams, Ignacio Vázquez-García, Grittney Tam, et al.
Leukemia|May 15, 2007
A comprehensive genetic and histopathologic analysis identifies two subgroups of B-cell malignancies carrying a t(14;19)(q32;q13) or variant BCL3-translocationJ I Martín-Subero, R Ibbotson, W Klapper, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 11, 2018
Ado-Trastuzumab Emtansine for Patients With HER2-Mutant Lung Cancers: Results From a Phase II Basket TrialBob T Li, Ronglai Shen, Darren Buonocore, et al.
Trials|February 24, 2022
CeRebrUm and CardIac Protection with ALlopurinol in Neonates with Critical Congenital Heart Disease Requiring Cardiac Surgery with Cardiopulmonary Bypass (CRUCIAL): study protocol of a phase III, randomized, quadruple-blinded, placebo-controlled, Dutch multicenter trialRaymond Stegeman, Maaike Nijman, Johannes M P J Breur, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 3, 2022
Phase Ib Trial of the Combination of Imatinib and Binimetinib in Patients with Advanced Gastrointestinal Stromal TumorsPing Chi, Li-Xuan Qin, Niedzica Camacho, et al.
Cancer|August 5, 2021
Pancreas cancer and BRCA: A critical subset of patients with improving therapeutic outcomesParisa Momtaz, Catherine A O'Connor, Joanne F Chou, et al.
Cancer Cell|October 27, 2023
Tumor sequencing of African ancestry reveals differences in clinically relevant alterations across common cancersEvelyn Jiagge, Dexter X Jin, Justin Y Newberg, et al.
Gynecologic Oncology|May 7, 2023
Germline drivers of gynecologic carcinosarcomasTiffany Y Sia, Sushmita B Gordhandas, Ozge Birsoy, et al.
Cell|December 19, 2024
Pan-cancer analysis of biallelic inactivation in tumor suppressor genes identifies KEAP1 zygosity as a predictive biomarker in lung cancerMark Zucker, Maria A Perry, Samuel I Gould, et al.
JCO Precision Oncology|September 16, 2025
Clinical Utility and Prognostic Implications of Circulating Cell-Free DNA in Biliary Tract CancerDarren Cowzer, Madison Darmofal, Kenneth Seier, et al.
Pageof 117